Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP). ADMET DMPK [Internet]. 2016 Dec. 26 [cited 2025 Nov. 17];4(4):302-13. Available from: https://pub.iapchem.org/ojs/index.php/admet/article/view/322